Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

The UK Sepsis Trust

HCP icons in Cuttsy+Cuttsy branded shapes

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Cuttsy + Cuttsy

- PMLiVE

ABPI publishes new prescribing support guide for healthcare professionals

The report will help pharmaceutical companies support high-quality healthcare

- PMLiVE

NICE recommends better targeting of antibiotics for suspected sepsis

It is hoped that the new guidance will reduce the risk of antibiotic resistance by ensuring antibiotics are targeted to those at the greatest risk

- PMLiVE

Havas Lynx Group launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx Group, has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

Havas Lynx

- PMLiVE

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

Havas Lynx

Creating content for healthcare professionals

How to create content for health professionals

Catching the attention of time-strapped healthcare professionals is hard, but not impossible.

Springer Nature

- PMLiVE

NHS Digital Health Check begins trial to ease pressure on services

The digital service could prevent around 1,600 heart attacks and strokes per year

- PMLiVE

Proving the power of a positive mindset to help fix all ills

There’s a huge amount of fear around health conditions and disease – in fact according to Harvard Medical School, health anxiety affects 12% of adults. We wanted to put a...

Create Health

- PMLiVE

UK to provide genomic sequencing globally to identify COVID-19 variants

Public Health England has identified the first group of countries to receive genomic sequencing support through NVAP

- PMLiVE

COVID-19 booster dose programme planned for September launch in Britain

The programme will be conducted in two stages for a range of priority groups

- PMLiVE

Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses

Pfizer/BioNTech and AZ vaccines found to be 96% and 92% effective against variant, respectively

- PMLiVE

UK plans to launch new national health agency focused on tackling pandemics

The UK Health Security Agency will protect against future health threats

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links